News from lightlake therapeutics inc A wide array of domestic and global news stories; news topics include politics / government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages, as well.

Apr 22, 2015, 09:00 ET

Lightlake Therapeutics Inc. Announces Adapt Pharma Limited Successfully Completed Intranasal Naloxone Study

Lightlake Therapeutics Inc. ("Lightlake") (OTCQB: LLTP), a biopharmaceutical company developing addiction treatments based on its expertise in...

Mar 10, 2015, 07:14 ET

La presentación del 5 de marzo de Lightlake Therapeutics Inc. ya está disponible para visualización bajo demanda

- La presentación del 5 de marzo de Lightlake Therapeutics Inc. en VirtualInvestorConferences.com ya está disponible para...

Mar 09, 2015, 15:13 ET

La présentation de Lightlake Therapeutics Inc. du 5 mars sur VirtualInvestorConferences.com est maintenant disponible pour être visionnée sur demande

- Lightlake invite les investisseurs individuels et institutionnels ainsi que les conseillers à se connecter à...

Mar 09, 2015, 10:00 ET

Die Präsentation von Lightlake Therapeutics Inc. auf VirtualInvestorConferences.com vom 5. März steht jetzt auf Abruf zu Verfügung

- Lightlake lädt individuelle und institutionelle Anleger sowie Berater dazu ein, sich bei VirtualInvestorConferences.com einzuloggen und die...

Mar 09, 2015, 09:00 ET

Lightlake Therapeutics Inc. March 5th Presentation At VirtualInvestorConferences.com Now Available For On-Demand Viewing

Lightlake invites individual and institutional investors as well as advisors to log-on to VirtualInvestorConferences.com to view the...

Feb 27, 2015, 09:00 ET

Lightlake Therapeutics Inc., Licensor Of A Treatment To Reverse Opioid Overdoses, To Webcast Live, At VirtualInvestorConferences.com March 5th

Lightlake invites individual and institutional investors to attend interactive real-time presentation on Lightlake's progress with its opioid...

Feb 17, 2015, 09:00 ET

Lightlake Therapeutics Inc. Announces Fast Track Designation From The United States Food And Drug Administration For Intranasal Naloxone Treatment To Reverse Opioid Overdose

Lightlake Therapeutics Inc. ("Lightlake") (OTCQB: LLTP), a biopharmaceutical company developing addiction treatments based on its expertise in...

Feb 09, 2015, 09:00 ET

Lightlake Therapeutics Inc. Announces Arvind Agrawal Appointed Executive Vice President, Medical Affairs

Lightlake Therapeutics Inc. ("Lightlake") (OTCQB: LLTP), a biopharmaceutical company developing addiction treatments based on its expertise in...

Dec 16, 2014, 08:30 ET

Lightlake Therapeutics Inc. Announces Licensing Deal With Adapt Pharma Limited Subsidiary

 Lightlake Therapeutics Inc. ("Lightlake") (OTCQB: LLTP), a biopharmaceutical company developing addiction treatments based on its expertise in...

Dec 04, 2014, 09:00 ET

Lightlake Therapeutics Commences Trial For Treatment Of Opioid Overdose With The U.S. National Institute On Drug Abuse (NIDA)

 Lightlake Therapeutics Inc. ("Lightlake") (OTCQB: LLTP), a biopharmaceutical company developing addiction treatments based on its expertise in...

Oct 02, 2014, 08:30 ET

Lightlake Therapeutics Inc. Announces Closing Of Investments In Two Products

 Lightlake Therapeutics Inc. ("Lightlake") (OTCQB: LLTP), a biopharmaceutical company developing addiction treatments based on its...

Jul 30, 2014, 08:30 ET

Lightlake Therapeutics Inc. Receives Funding Commitment From A Prominent International Research And Development Foundation

 Lightlake Therapeutics Inc. ("Lightlake") (OTCQB: LLTP), a biopharmaceutical company developing addiction treatments based on its expertise in...

Jul 23, 2014, 08:30 ET

Lightlake Therapeutics Inc. Files Investigational New Drug Application For Naloxone Nasal Spray For Reversing Opioid Overdose And Announces A Further Collaboration With The National Institute On Drug Abuse

 Lightlake Therapeutics Inc. ("Lightlake") (OTCQB: LLTP), a biopharmaceutical company developing addiction treatments based on its expertise in...

Jul 09, 2014, 08:30 ET

Lightlake Therapeutics Inc. Signs Agreement With Commercial Contract Manufacturer For Its Opioid Overdose Reversal Treatment

Lightlake Therapeutics Inc. ("Lightlake") (OTCQB: LLTP), a biopharmaceutical company developing addiction treatments based on its expertise in...

May 22, 2014, 08:30 ET

Lightlake Therapeutics Inc. To Present At The Third Annual Marcum MicroCap Conference

 Lightlake Therapeutics Inc. ("Lightlake") (OTC BB: LLTP), a biopharmaceutical company developing addiction treatments based on its expertise...

Dec 20, 2013, 09:00 ET

Lightlake Therapeutics Inc. Chief Executive Officer Letter to Shareholders

 Lightlake Therapeutics Inc. ("Lightlake" or the "Company") (OTC BB: LLTP), a biopharmaceutical company developing addiction treatments based...

Dec 03, 2013, 16:05 ET

Initial Data from Lightlake Therapeutics Joint Clinical Trial with NIDA Shows Nasal Delivery of Naloxone for Opioid Overdose as a Promising Treatment

 Lightlake Therapeutics Inc. ("Lightlake" or the "Company") (OTC BB: LLTP), a biopharmaceutical company developing addiction treatments based...

Nov 20, 2013, 09:00 ET

Lightlake Therapeutics to Present at 6th Annual LD MICRO Conference

 Lightlake Therapeutics Inc. ("Lightlake" or the "Company") (OTC BB: LLTP), a biopharmaceutical company developing addiction treatments based...

Sep 24, 2013, 08:30 ET

Lightlake Therapeutics Commences Two-Week Patient Trial for Treatment of Opioid Overdose with National Institute on Drug Abuse (NIDA)

Lightlake Therapeutics Inc. ("Lightlake" or the "Company") (OTC BB: LLTP), a biopharmaceutical company developing addiction treatments based on its...

Aug 21, 2013, 08:30 ET

Lightlake Therapeutics Announces Partnership with National Institute on Drug Abuse (NIDA) to Treat Opioid Overdose

 Lightlake Therapeutics Inc., ("Lightlake" or the "Company") (OTC BB: LLTP), a biopharmaceutical company developing addiction treatments based...